89 related articles for article (PubMed ID: 27672310)
1. Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents.
Zapata-Sudo G; da Costa Nunes IK; Araujo JS; da Silva JS; Trachez MM; da Silva TF; da Costa FP; Sudo RT; Barreiro EJ; Lima LM
Drug Des Devel Ther; 2016; 10():2869-2879. PubMed ID: 27672310
[TBL] [Abstract][Full Text] [Related]
2. Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists.
Zapata-Sudo G; Lima LM; Pereira SL; Trachez MM; da Costa FP; Souza BJ; Monteiro CE; Romeiro NC; D'Andrea ÉD; Sudo RT; Barreiro EJ
Curr Top Med Chem; 2012; 12(19):2037-48. PubMed ID: 23167793
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.
Huang Q; Chen Y; Gong N; Wang YX
Metabolism; 2016 Apr; 65(4):463-74. PubMed ID: 26975538
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes.
Lacerda RB; de Lima CK; da Silva LL; Romeiro NC; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2009 Jan; 17(1):74-84. PubMed ID: 19059783
[TBL] [Abstract][Full Text] [Related]
6. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
Kuhad A; Chopra K
Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
[TBL] [Abstract][Full Text] [Related]
7. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Kuhad A; Sharma S; Chopra K
Eur J Pain; 2008 Jul; 12(5):624-32. PubMed ID: 18055235
[TBL] [Abstract][Full Text] [Related]
8. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system.
Banafshe HR; Hamidi GA; Noureddini M; Mirhashemi SM; Mokhtari R; Shoferpour M
Eur J Pharmacol; 2014 Jan; 723():202-6. PubMed ID: 24315931
[TBL] [Abstract][Full Text] [Related]
9. Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Mansoori M; Soltani N
Diabetes Res Clin Pract; 2006 Jul; 73(1):17-22. PubMed ID: 16417942
[TBL] [Abstract][Full Text] [Related]
10. Antihyperalgesic and antiallodynic effects of mianserin on diabetic neuropathic pain: a study on mechanism of action.
Üçel Uİ; Can ÖD; Demir Özkay Ü; Öztürk Y
Eur J Pharmacol; 2015 Jun; 756():92-106. PubMed ID: 25771454
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
Beyreuther B; Callizot N; Stöhr T
Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats.
Yamamoto H; Shimoshige Y; Yamaji T; Murai N; Aoki T; Matsuoka N
Neuropharmacology; 2009 Sep; 57(4):403-8. PubMed ID: 19591853
[TBL] [Abstract][Full Text] [Related]
13. Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive
Guedes JS; Carneiro TR; Pinheiro PSM; Fraga CAM; Sant Anna CMR; Barreiro EJ; Lima LM
ACS Omega; 2022 Nov; 7(43):38752-38765. PubMed ID: 36340078
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Sharma S; Kulkarni SK; Agrewala JN; Chopra K
Eur J Pharmacol; 2006 May; 536(3):256-61. PubMed ID: 16584726
[TBL] [Abstract][Full Text] [Related]
15. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
Pabreja K; Dua K; Sharma S; Padi SS; Kulkarni SK
Eur J Pharmacol; 2011 Jul; 661(1-3):15-21. PubMed ID: 21536024
[TBL] [Abstract][Full Text] [Related]
16. Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Katz NK; Ryals JM; Wright DE
Neuroscience; 2015 Jan; 285():312-23. PubMed ID: 25451280
[TBL] [Abstract][Full Text] [Related]
17. Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats.
Mendes TC; Antunes F; Trachez MM; Nascimento NM; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):404-11. PubMed ID: 23573962
[TBL] [Abstract][Full Text] [Related]
18. Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats.
Chen YW; Hsieh PL; Chen YC; Hung CH; Cheng JT
Anesth Analg; 2013 Feb; 116(2):482-90. PubMed ID: 23302966
[TBL] [Abstract][Full Text] [Related]
19. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
